IHS Chemical Week

People & Business :: Companies

Abbott to Acquire Piramal’s Indian Branded Generics Business for $3.72 Billion

4:25 AM MDT | May 21, 2010 | Deepti Ramesh

Abbott Laboratories (Abbott Park, IL) says it has signed a definitive agreement with Piramal Healthcare (Mumbai) to acquire full ownership of Piramal's healthcare solutions business (domestic formulations business), for an up-front payment of $2.12 billion, plus $400 million/year for the next four years. Piramal’s healthcare solutions business is the leader in the Indian branded generics market, and the acquisition will give Abbott the top position in the Indian pharmaceutical market, Abbott says. The transaction is expected to close in the second half of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa